Staburo at the APF autumn meeting in Freiburg organized by Roche

Staburo at the APF autumn meeting in Freiburg organized by Roche

APF meeting 2017 on Estimands and Safety in Freiburg

Staburo participated in the APF meeting on 24 November 2017 in Freiburg. This year, the APF was hosted by Roche. Speakers from pharmaceutical industry, academia and regulatory agencies discussed important topics on estimands, safety and Health Technlogy Assessment.

The APF (Arbeitsgruppe Pharmazeutische Forschung) is a German pharmaceutical research working group for statisticians in the pharmaceutical and healthcare industry, academia and regulatory agencies. The APF is part of the International Biometric Society.

We also attended the get-together on 23 November 2017 at the restaurant Großer Meyerhof. It was a great opportunity to meet other statisticians.

The Staburo team wishes you a Merry Christmas and a happy 2018!

The Staburo team wishes you a Merry Christmas and a happy 2018!

Staburo wishes you a Merry Christmas and a Happy New Year

Big steps for Staburo in 2017

Last year was very successful for our company. Our major milestones were:

  • Strategy workshop with Mission & Vision for 2022
  • Further internationalization with additional US, EU and UK projects
  • New big pharma & new biomarker project
  • Four new employees during 2017 + several interns
  • Goals for net sales and FTEs achieved
  • Moving to a new, bigger office space

We thank our employees and clients, who helped us, to make all of this happen!

We wish all partners and future partners, our employees, and their families a wonderful Christmas and a great start in 2018.

Staburo will continue to support you with experienced biostatisticians and statistical programmers next year and in the years to come! Thank you!

Staburo attended 2nd Annual Biosimilars Forum

Staburo attended 2nd Annual Biosimilars Forum

2nd Annual Biosimilars Forum (1)

The 2nd Annual Biosimilars Forum was hosted in Budapest in October 2017. Clinicians, statisticians and regulatory representatives from around the world gathered here, to share with each other their perspectives on this hot topic of research, in lectures and informal discussions. The professional lectures of the event reflected the challenges in this special and complex field of drug development.

Use Staburo’s expertise with biosimilars

Staburo is already supporting several biosimilars companies in the development of their biosimilar drugs. We are involved in the stability and similarity testing at an analytical level, according to the latest draft FDA guidelines and EMA reflection paper. Besides this, we bring our statistical knowledge into the companies for innovative study designs and plan state-of-the-art statistical analyses that are key for bringing biosimilars to the market as fast as possible.


Staburo at the WiMa17 Congress at the University Ulm

Staburo at the WiMa17 Congress at the University Ulm

Staburo WIMA Universität Ulm 2017

Staburo took part in the WiMa17 Congress at the University Ulm. The WiMa Congress is a networking forum for companies and students from a mathematics, finance, IT, and biometry background.

At the WiMa Congress, companies have the opportunity to present themselves, get in contact with their possible future employees and have personal interview sessions with them. Furthermore, there are different presentations on very interesting topics, during the entire day. Staburo provided insights into crossover correction methods in oncology, as well as an overview on other offered services and the work of biostatisticians and statistical programmers in clinical research. A current employee, who studied medical biometry at Ulm University also shared a short personal testimonial about her start at Staburo.

A big thank you for inviting us and for the great organisation of this event. We will definitely come back next year!